Canadian Biomaterials Society
La Société Canadienne des Biomatériaux

Dear CBS Members, This is a friendly reminder that the abstract deadline for CBS2025 is today Submit your abstracts here...

Calling all ECR Faculty Members for Keynote Presentation Opportunities Dear CBS Members, A feature of CBS2025 will be presentations from current Early Career Researcher ECR faculty member highlighting their expertise and new research...

CBS2025 abstract submission deadline is extended until February 7th We know it is a busy time of year and so we are happy to announce that the CBS 2025 abstract submission deadline for the 39th Annual Meeting of the Canadian Biomaterial Society has been extended until February 7th, 2025 please note that this will be the last extension The CBS2025 Organizing Committee invites you to submit your abstracts related to biomaterials research through the Oxford Abstracts submission portal...

Happy Monday There are two upcoming events that may be of interest to CBS members and our local biomaterials community...

Primary amine-rich C-NH2 surfaces have shown great interest to foster cell adhesion and growth, or efficient covalent immobilization of bioactive molecules to induce specific interactions with cells...

Metals currently used for prosthetic reconstructions e.g. titanium possess a relatively good success rate, but their performance drops significantly in patients with compromised health status...

Magnesium alloys have the highest strength weight ratio of all known structural metals. They are a third lighter than aluminum and a quarter the density of steel...

Thermosensitive chitosan CH -based hydrogels that rapidly pass from a liquid at room temperature to a mechanically stable solid at body temperature without any crosslinker show excellent potential for tissue engineering applications and could be interesting candidates for bioprinting ADDIN EN...

Cell surface integrins play important roles in the survival, proliferation, migration and invasion of cancer cells, and is a viable target for the treatment of metastatic breast cancer1...